BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3525789)

  • 21. Comparison of classic and quantitative prognostic factors in colorectal cancer.
    Ropponen K; Eskelinen M; Kosma VM; Lipponen P; Paakkinen P; Alhava E
    Anticancer Res; 1996; 16(6B):3875-82. PubMed ID: 9042274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.
    Rosenberg R; Friederichs J; Schuster T; Gertler R; Maak M; Becker K; Grebner A; Ulm K; Höfler H; Nekarda H; Siewert JR
    Ann Surg; 2008 Dec; 248(6):968-78. PubMed ID: 19092341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staging of carcinoma of the colon and rectum.
    Terrazas JM; Val-Bernal JF; Buelta L
    Surg Gynecol Obstet; 1987 Sep; 165(3):255-9. PubMed ID: 3629440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Global prognosis and stage classification of colorectal carcinoma].
    Terrazas Hontañón JM; Val Bernal JF; Buelta Carrillo L
    Rev Esp Oncol; 1985; 32(2):323-41. PubMed ID: 3843465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis.
    Halvorsen TB; Seim E
    J Clin Pathol; 1988 Oct; 41(10):1068-72. PubMed ID: 2848059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer in the young patient.
    Minardi AJ; Sittig KM; Zibari GB; McDonald JC
    Am Surg; 1998 Sep; 64(9):849-53. PubMed ID: 9731812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
    Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B
    Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal cancer staging as a prognostic feature.
    Beahrs OH
    Cancer; 1982 Dec; 50(11 Suppl):2615-7. PubMed ID: 7139556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
    Werther K; Christensen IJ; Brünner N; Nielsen HJ
    Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin in fore-gut carcinoids. A survey of 60 cases with regard to silver stains, formalin-induced fluorescence and serotonin immunocytochemistry.
    Wilander E; Lundqvist M; el-Salhy M
    J Pathol; 1985 Mar; 145(3):251-8. PubMed ID: 2580071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer in young patients: characteristics and outcome.
    Lee PY; Fletcher WS; Sullivan ES; Vetto JT
    Am Surg; 1994 Aug; 60(8):607-12. PubMed ID: 8030817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
    Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
    Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of specific histologic features of carcinoma of the colon and rectum.
    de Mascarel A; Coindre JM; de Mascarel I; Trojani M; Marée D; Hoerni B
    Surg Gynecol Obstet; 1981 Oct; 153(4):511-4. PubMed ID: 7280939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Young age is not a poor prognostic marker in colorectal cancer.
    Chung YF; Eu KW; Machin D; Ho JM; Nyam DC; Leong AF; Ho YH; Seow-Choen F
    Br J Surg; 1998 Sep; 85(9):1255-9. PubMed ID: 9752871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the histochemical changes in mucus from normal and tumour bearing mucosa in patients with colorectal cancer.
    Habib NA; Dawson PM; Blount MA; Cox S; Krausz T; Wood CB
    Eur J Surg Oncol; 1985 Sep; 11(3):243-5. PubMed ID: 4029403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of secretory component (SC) immunoreactivity in diagnosis and prognosis of colorectal carcinomas.
    Arends JW; Wiggers T; Thijs CT; Verstijnen C; Swaen GJ; Bosman FT
    Am J Clin Pathol; 1984 Sep; 82(3):267-74. PubMed ID: 6465093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal cancer-associated antigen (GICA) immunoreactivity in colorectal carcinoma in relation to patient survival.
    Arends JW; Wiggers T; Verstijnen C; Hilgers J; Bosman FT
    Int J Cancer; 1984 Aug; 34(2):193-6. PubMed ID: 6381331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human chorionic gonadotropin in colorectal cancer and its relationship to prognosis.
    Yamaguchi A; Ishida T; Nishimura G; Kumaki T; Katoh M; Kosaka T; Yonemura Y; Miyazaki I
    Br J Cancer; 1989 Sep; 60(3):382-4. PubMed ID: 2789946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunoperoxidases in the study of hormone receptors in colorectal cancer].
    Caruso ML; Valentini AM
    Pathologica; 1987; 79(1059-1060):223-7. PubMed ID: 3327045
    [No Abstract]   [Full Text] [Related]  

  • 40. Methane production in patients with colorectal carcinoma.
    Kashtan H; Rabau M; Peled Y; Milstein A; Wiznitzer T
    Isr J Med Sci; 1989 Nov; 25(11):614-6. PubMed ID: 2592175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.